U.S. patent disclosures
Tuesday, April 22, 2014
Auspex Pharmaceuticals Inc., of La Jolla, Calif., was issued U.S. Patent No. 8,680,123 and No. 8,383,823, related to the method of treatment, prevention or amelioration of fibrotic conditions such as idiopathic pulmonary fibrosis with SD-560, and the composition of matter for the same product, respectively.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.